80 related articles for article (PubMed ID: 20409772)
1. Recent trends in breast cancer incidence rates in the Loire-Atlantique, France: a decline since 2003.
Fontenoy AM; Leux C; Delacour-Billon S; Allioux C; Frenel JS; Campone M; Molinié F
Cancer Epidemiol; 2010 Jun; 34(3):238-43. PubMed ID: 20409772
[TBL] [Abstract][Full Text] [Related]
2. Recent trends in breast cancer incidence rates by age and tumor characteristics among U.S. women.
Jemal A; Ward E; Thun MJ
Breast Cancer Res; 2007; 9(3):R28. PubMed ID: 17477859
[TBL] [Abstract][Full Text] [Related]
3. Reductions in use of hormone replacement therapy: effects on Swedish breast cancer incidence trends only seen after several years.
Lambe M; Wigertz A; Holmqvist M; Adolfsson J; Bardage C; Fornander T; Karlsson P; Odlind V; Persson I; Ahlgren J; Bergkvist L
Breast Cancer Res Treat; 2010 Jun; 121(3):679-83. PubMed ID: 19894110
[TBL] [Abstract][Full Text] [Related]
4. [Incidence and prognostic factors of breast cancer diagnosed within and outside of the organised screening program in the department of Loire-Atlantique (1991-2002)].
Molinié F; Billon-Delacour S; Allioux C; Blais S; Bercelli P; Lombrail P
Rev Epidemiol Sante Publique; 2008 Feb; 56(1):41-9. PubMed ID: 18295424
[TBL] [Abstract][Full Text] [Related]
5. [Decline in breast cancer incidence in 2005 and 2006 in France: a paradoxical trend].
Allemand H; Seradour B; Weill A; Ricordeau P
Bull Cancer; 2008 Jan; 95(1):11-5. PubMed ID: 18230565
[TBL] [Abstract][Full Text] [Related]
6. Reduced risk of oestrogen receptor positive breast cancer among peri- and post-menopausal women in Scotland following a striking decrease in use of hormone replacement therapy.
Sharpe KH; McClements P; Clark DI; Collins J; Springbett A; Brewster DH
Eur J Cancer; 2010 Mar; 46(5):937-43. PubMed ID: 20122823
[TBL] [Abstract][Full Text] [Related]
7. Population-based hormone receptor-specific incidence trends of breast cancer in Germany.
Rusner C; Bandemer-Greulich U; Engel J; Stegmaier C; Zawinell A; Holleczek B; Katalinic A; Kuss O; Schmidt-Pokrzywniak A; Schubert-Fritschle G; Tillack A; Stang A
Maturitas; 2012 Oct; 73(2):152-7. PubMed ID: 22785007
[TBL] [Abstract][Full Text] [Related]
8. Decline in breast cancer incidence after decrease in utilisation of hormone replacement therapy.
Katalinic A; Rawal R
Breast Cancer Res Treat; 2008 Feb; 107(3):427-30. PubMed ID: 17453336
[TBL] [Abstract][Full Text] [Related]
9. Association of hormone replacement therapy to estrogen and progesterone receptor status in invasive breast carcinoma.
Chen WY; Hankinson SE; Schnitt SJ; Rosner BA; Holmes MD; Colditz GA
Cancer; 2004 Oct; 101(7):1490-500. PubMed ID: 15378477
[TBL] [Abstract][Full Text] [Related]
10. Seasonal variation in breast cancer diagnosis in Singapore.
Gao F; Machin D; Khoo KS; Ng EH
Br J Cancer; 2001 May; 84(9):1185-7. PubMed ID: 11336468
[TBL] [Abstract][Full Text] [Related]
11. The incidence of breast cancer and changes in the use of hormone replacement therapy: a review of the evidence.
Verkooijen HM; Bouchardy C; Vinh-Hung V; Rapiti E; Hartman M
Maturitas; 2009 Oct; 64(2):80-5. PubMed ID: 19709827
[TBL] [Abstract][Full Text] [Related]
12. Changing pattern of age-specific breast cancer incidence in the Swiss canton of Geneva.
Bouchardy C; Usel M; Verkooijen HM; Fioretta G; Benhamou S; Neyroud-Caspar I; Schaffar R; Vlastos G; Wespi Y; Schäfer P; Rapiti E
Breast Cancer Res Treat; 2010 Apr; 120(2):519-23. PubMed ID: 19633953
[TBL] [Abstract][Full Text] [Related]
13. Disentangling the roles of mammographic screening and HRT in recent breast cancer incidence trends in italy by analyses based on calendar time and time since screening activation.
Crocetti E; Buzzoni C; Falcini F; Cortesi L; De Lisi V; Ferretti S; Tumino R; Russo A; Paci E
Breast J; 2010; 16(4):350-5. PubMed ID: 20443789
[TBL] [Abstract][Full Text] [Related]
14. Breast cancer incidence and hormone replacement therapy: results from the MISSION study, prospective phase.
Espié M; Daures JP; Chevallier T; Mares P; Micheletti MC; De Reilhac P
Gynecol Endocrinol; 2007 Jul; 23(7):391-7. PubMed ID: 17701770
[TBL] [Abstract][Full Text] [Related]
15. The association of infrared imaging findings of the breast with hormone receptor and human epidermal growth factor receptor 2 status of breast cancer.
Wang J; Shih TT; Yen RF; Lu YS; Chen CY; Mao TL; Lin CH; Kuo WH; Tsai YS; Chang KJ; Chien KL
Acad Radiol; 2011 Feb; 18(2):212-9. PubMed ID: 21126889
[TBL] [Abstract][Full Text] [Related]
16. The breast cancer "plunge" after initial publication of the WHI results: an alternative explanation.
Simon JA; Nahum GG; Stanislaw H; Gaines T
Maturitas; 2010 Jul; 66(3):277-84. PubMed ID: 20471761
[TBL] [Abstract][Full Text] [Related]
17. Hormone replacement therapy before breast cancer diagnosis significantly reduces the overall death rate compared with never-use among 984 breast cancer patients.
Jernström H; Frenander J; Fernö M; Olsson H
Br J Cancer; 1999 Jul; 80(9):1453-8. PubMed ID: 10424750
[TBL] [Abstract][Full Text] [Related]
18. Dissemination of adjuvant multiagent chemotherapy and tamoxifen for breast cancer in the United States using estrogen receptor information: 1975-1999.
Mariotto AB; Feuer EJ; Harlan LC; Abrams J
J Natl Cancer Inst Monogr; 2006; (36):7-15. PubMed ID: 17032888
[TBL] [Abstract][Full Text] [Related]
19. Hormone replacement therapy, mammography screening and changing age-specific incidence rates of breast cancer: an ecological study comparing two European populations.
Verkooijen HM; Koot VC; Fioretta G; van der Heiden M; Schipper ME; Rapiti E; Peeters PH; Peterse JL; Bouchardy C
Breast Cancer Res Treat; 2008 Feb; 107(3):389-95. PubMed ID: 17431760
[TBL] [Abstract][Full Text] [Related]
20. [Did the decrease in use of menopausal hormone therapy induce a decrease in the incidence of breast cancer in France (and elsewhere)?].
Ringa V; Fournier A
Rev Epidemiol Sante Publique; 2008 Oct; 56(5):297-301. PubMed ID: 18947946
[No Abstract] [Full Text] [Related]
[Next] [New Search]
